Imeros

Mepivacaine, the active ingredient in Imeros, is a local anesthetic presented as an injectable solution for infiltration and perineural use. It provides reversible nerve blockade to achieve local anesthesia during minor surgical procedures, peripheral nerve blocks, and dental treatments.

GNH USA supplies Imeros as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and offers reliable global distribution. Customers benefit from consistent product availability and regulatory compliance.

Mepivacaine is used as a local anesthetic for procedures requiring temporary nerve blockade.

- Infiltration anesthesia: provides localized numbness for minor surgical or diagnostic procedures. - Peripheral nerve block: enables regional anesthesia for limb surgeries or pain management. - Dental anesthesia: facilitates pain‑free dental extractions, restorations and other oral procedures.

Mepivacaine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Pain, burning or tingling at the injection site. - Mild dizziness or light‑headedness. - Nausea or transient metallic taste. - Temporary blurred vision.

Serious or Rare Side Effects: - Allergic reactions such as rash, swelling or anaphylaxis. - Seizures or central nervous system toxicity. - Cardiac arrhythmias or severe hypotension.

When using Mepivacaine, clinicians should observe several safety measures.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Dose minimization: use the lowest effective volume for the intended procedure. - Cardiovascular monitoring: observe heart rate and blood pressure during regional blocks. - Hepatic function: exercise caution in patients with severe liver disease. - Pregnancy considerations: avoid unless benefit outweighs potential risk. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Mepivacaine can interact with other medications, altering its safety profile.

Major Interactions (Avoid): - Class I anti‑arrhythmic agents (e.g., quinidine, procainamide). - Beta‑blockers that may potentiate cardiac depression. - MAO inhibitors that increase risk of severe hypotension.

Moderate Interactions (Monitor Closely): - Epinephrine: may increase systemic absorption and toxicity. - Central nervous system depressants (e.g., benzodiazepines, opioids). - Calcium‑channel blockers. - Other local anesthetics used concurrently. - Drugs affecting hepatic metabolism such as cimetidine.